Mandate

Vinge advises Djursjukhusgruppen in connection with acquisition of Arboga Djurklinik

March 22, 2013

​Vinge has advised Djursjukhusgruppen in connection with the acquisition of Arboga Djurklinik AB. Djursjukhusgruppen is the Nordic region’s leading group within expert veterinary care for dogs, cats and other household pets, with staff who have a high degree of specialisation as well as modern and advanced technology.

Vinge’s team consisted of responsible partner Jonas Bergström together with, among others, associates Gustav Jönsson and Magnus Wieslander.

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024